TCIM
TTPH
TIAA CREF Investment Management’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | $130K | Sell |
97,364
-1,476
| -1% | -$1.97K | ﹤0.01% | 2934 |
|
2018
Q4 | $112K | Hold |
98,840
| – | – | ﹤0.01% | 2949 |
|
2018
Q3 | $273K | Sell |
98,840
-48,995
| -33% | -$135K | ﹤0.01% | 2911 |
|
2018
Q2 | $528K | Sell |
147,835
-15,084
| -9% | -$53.9K | ﹤0.01% | 2763 |
|
2018
Q1 | $500K | Buy |
162,919
+45,266
| +38% | +$139K | ﹤0.01% | 2737 |
|
2017
Q4 | $741K | Sell |
117,653
-4,769
| -4% | -$30K | ﹤0.01% | 2606 |
|
2017
Q3 | $837K | Buy |
122,422
+22,503
| +23% | +$154K | ﹤0.01% | 2606 |
|
2017
Q2 | $712K | Sell |
99,919
-61,768
| -38% | -$440K | ﹤0.01% | 2705 |
|
2017
Q1 | $1.49M | Buy |
161,687
+34,515
| +27% | +$317K | ﹤0.01% | 2311 |
|
2016
Q4 | $513K | Sell |
127,172
-73,608
| -37% | -$297K | ﹤0.01% | 2842 |
|
2016
Q3 | $769 | Sell |
200,780
-29,978
| -13% | -$115 | ﹤0.01% | 2665 |
|
2016
Q2 | $992K | Buy |
230,758
+49,622
| +27% | +$213K | ﹤0.01% | 2510 |
|
2016
Q1 | $839K | Hold |
181,136
| – | – | ﹤0.01% | 2577 |
|
2015
Q4 | $1.82M | Sell |
181,136
-1,060
| -0.6% | -$10.6K | ﹤0.01% | 2217 |
|
2015
Q3 | $1.36M | Buy |
182,196
+25,061
| +16% | +$187K | ﹤0.01% | 2382 |
|
2015
Q2 | $7.45M | Buy |
157,135
+51,990
| +49% | +$2.47M | 0.01% | 1368 |
|
2015
Q1 | $3.85M | Buy |
105,145
+8,325
| +9% | +$305K | ﹤0.01% | 1810 |
|
2014
Q4 | $3.85M | Buy |
96,820
+17,241
| +22% | +$685K | ﹤0.01% | 1817 |
|
2014
Q3 | $1.59M | Sell |
79,579
-3,944
| -5% | -$78.7K | ﹤0.01% | 2375 |
|
2014
Q2 | $1.13M | Buy |
83,523
+38,004
| +83% | +$513K | ﹤0.01% | 2650 |
|
2014
Q1 | $496K | Hold |
45,519
| – | – | ﹤0.01% | 2938 |
|
2013
Q4 | $615K | Hold |
45,519
| – | – | ﹤0.01% | 2902 |
|
2013
Q3 | $518K | Buy |
45,519
+1,033
| +2% | +$11.8K | ﹤0.01% | 2924 |
|
2013
Q2 | $313K | Buy |
+44,486
| New | +$313K | ﹤0.01% | 3021 |
|